Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
622 | 3151 | 37.1 | 80% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MORRIS HEPATOMA 5123 | Author keyword | 20 | 100% | 0% | 9 |
2 | TNF RECEPTORS | Author keyword | 7 | 21% | 1% | 29 |
3 | ENDOGENOUS TNF ALPHA | Author keyword | 6 | 80% | 0% | 4 |
4 | SOLUBLE TNF RECEPTORS | Author keyword | 6 | 30% | 1% | 16 |
5 | TEACHING WARD INTERNAL MED | Address | 6 | 100% | 0% | 4 |
6 | TNF CYTOTOXICITY | Author keyword | 6 | 100% | 0% | 4 |
7 | MUTEINS | Author keyword | 5 | 60% | 0% | 6 |
8 | TUMOR NECROSIS FACTOR RECEPTOR | Author keyword | 5 | 17% | 1% | 28 |
9 | LYMPHOKINE AND CYTOKINE RESEARCH | Journal | 5 | 14% | 1% | 34 |
10 | LYMPHOTOXIN | Author keyword | 5 | 16% | 1% | 29 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MORRIS HEPATOMA 5123 | 20 | 100% | 0% | 9 | Search MORRIS+HEPATOMA+5123 | Search MORRIS+HEPATOMA+5123 |
2 | TNF RECEPTORS | 7 | 21% | 1% | 29 | Search TNF+RECEPTORS | Search TNF+RECEPTORS |
3 | ENDOGENOUS TNF ALPHA | 6 | 80% | 0% | 4 | Search ENDOGENOUS+TNF+ALPHA | Search ENDOGENOUS+TNF+ALPHA |
4 | SOLUBLE TNF RECEPTORS | 6 | 30% | 1% | 16 | Search SOLUBLE+TNF+RECEPTORS | Search SOLUBLE+TNF+RECEPTORS |
5 | TNF CYTOTOXICITY | 6 | 100% | 0% | 4 | Search TNF+CYTOTOXICITY | Search TNF+CYTOTOXICITY |
6 | MUTEINS | 5 | 60% | 0% | 6 | Search MUTEINS | Search MUTEINS |
7 | TUMOR NECROSIS FACTOR RECEPTOR | 5 | 17% | 1% | 28 | Search TUMOR+NECROSIS+FACTOR+RECEPTOR | Search TUMOR+NECROSIS+FACTOR+RECEPTOR |
8 | LYMPHOTOXIN | 5 | 16% | 1% | 29 | Search LYMPHOTOXIN | Search LYMPHOTOXIN |
9 | TNF RECEPTOR | 5 | 16% | 1% | 29 | Search TNF+RECEPTOR | Search TNF+RECEPTOR |
10 | TNF MUTANT | 4 | 75% | 0% | 3 | Search TNF+MUTANT | Search TNF+MUTANT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FACTOR TNF RECEPTOR | 90 | 53% | 4% | 120 |
2 | FACTOR TNF | 49 | 33% | 4% | 121 |
3 | HUMAN LYMPHOTOXIN | 30 | 57% | 1% | 35 |
4 | CACHECTIN | 26 | 13% | 6% | 190 |
5 | 55 KDA | 23 | 76% | 1% | 16 |
6 | FACTOR CACHECTIN | 22 | 19% | 3% | 107 |
7 | FACTOR BINDING PROTEIN | 21 | 16% | 4% | 125 |
8 | MANGANOUS SUPEROXIDE DISMUTASE | 20 | 33% | 2% | 50 |
9 | LYMPHOTOXIN | 20 | 16% | 4% | 111 |
10 | HUMAN CANCER PATIENTS | 19 | 80% | 0% | 12 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LYMPHOKINE AND CYTOKINE RESEARCH | 5 | 14% | 1% | 34 |
2 | LYMPHOKINE RESEARCH | 4 | 12% | 1% | 34 |
3 | JOURNAL OF INFLAMMATION | 2 | 14% | 0% | 11 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
TUMOR-NECROSIS-FACTOR - A PLEIOTROPIC CYTOKINE AND THERAPEUTIC TARGET | 1994 | 761 | 58 | 60% |
2 TUMOR-NECROSIS-FACTOR RECEPTORS - STRUCTURE AND FUNCTION | 1995 | 575 | 69 | 70% |
The tumor necrosis factor ligand and receptor families | 1996 | 797 | 76 | 30% |
THE BIOLOGY OF CACHECTIN/TNF - A PRIMARY MEDIATOR OF THE HOST RESPONSE | 1989 | 1557 | 182 | 53% |
Tumor necrosis factor receptor and Fas signaling mechanisms | 1999 | 951 | 203 | 19% |
TUMOR-NECROSIS-FACTOR - CHARACTERIZATION AT THE MOLECULAR, CELLULAR AND INVIVO LEVEL | 1991 | 627 | 121 | 69% |
TNF receptor subtype signalling: Differences and cellular consequences | 2002 | 363 | 392 | 32% |
TUMOR-NECROSIS-FACTOR - NEW INSIGHTS INTO THE MOLECULAR MECHANISMS OF ITS MULTIPLE ACTIONS | 1991 | 756 | 85 | 51% |
THE PATHOPHYSIOLOGY OF TUMOR NECROSIS FACTORS | 1992 | 1588 | 217 | 26% |
TNF alpha and the TNF receptor superfamily: Structure-function relationship(s) | 2000 | 225 | 104 | 38% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TEACHING WARD INTERNAL MED | 6 | 100% | 0.1% | 4 |
2 | UNIT MOL PATHOPHYSIOL EXPT THER Y | 3 | 50% | 0.1% | 4 |
3 | PATHOL TUMOR IMMUNOL | 2 | 31% | 0.2% | 5 |
4 | GYNECOL SEPT OBSTET | 1 | 38% | 0.1% | 3 |
5 | AID 1 | 1 | 100% | 0.1% | 2 |
6 | CYTOMETRY GRP | 1 | 50% | 0.1% | 2 |
7 | FED STATE BUDGETARY CLIN IMMUNOL | 1 | 50% | 0.1% | 2 |
8 | GENE THER Y BRANCH | 1 | 33% | 0.1% | 3 |
9 | CT REGENERAT BIOL | 1 | 40% | 0.1% | 2 |
10 | PATHOL TUMORIMMUNOL | 1 | 40% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000203192 | PHARMACEUT PROTE//PRE LIGAND BINDING ASSEMBLY DOMAIN PLAD//TUMOR NECROSIS FACTOR RECEPTOR TNFR |
2 | 0.0000135370 | IP PA1//INTEGRATED HOLIST IMMUNOL//BIOTECHNOL MIYAMAE KU |
3 | 0.0000107441 | LEUKOREGULIN//CYTOTOXIC LYMPHOKINE//BAL LYMPHOCYTES |
4 | 0.0000074452 | GENETIC RADIOTHERAPY//GENE RADIOTHERAPY//PEDIAT MICROBIOL IMMUNOL RADIOL |
5 | 0.0000071741 | ISOLATED LIMB PERFUSION//ISOLATED LIMB INFUSION//ISOLATED HEPATIC PERFUSION |
6 | 0.0000071161 | MTP PE//LIPOSOMAL MTP PE//L MTP PE |
7 | 0.0000065510 | MURINE PLASMACYTOMA//MICROENCAPSULATED CELLS//RECOMBINANT INTERLEUKIN 1 ALPHA |
8 | 0.0000053602 | ANTILIPID A//ELEBUTE SCORE//ANTIBIOTIC INDUCED ENDOTOXIN RELEASE |
9 | 0.0000052919 | H 411E CELLS//JIANG TANG KE LI JTKL//ADIPOCYTE SECRETED FACTORS |
10 | 0.0000051773 | TNF ALPHA GENE POLYMORPHISM//MOL LIFESCI//VA NEGOVSKY GEN REANIMATOL |